Search results
Results from the WOW.Com Content Network
Superbike World Championship (also known as WorldSBK, SBK, World Superbike, WSB, or WSBK) is a silhouette road racing series based on heavily modified production sports motorcycles. The championship was founded in 1988. The Superbike World Championship consists of a series of rounds held on permanent racing facilities.
Rifampicin, also known as rifampin, is an ansamycin antibiotic used to treat several types of bacterial infections, including tuberculosis (TB), Mycobacterium avium complex, leprosy, and Legionnaires' disease. [3]
The rifamycin group includes the classic rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, rifapentine, rifalazil and rifaximin. Rifamycin, sold under the trade name Aemcolo, is approved in the United States for treatment of travelers' diarrhea in some circumstances. [1] [2] [3]
A new race format was introduced for the 2019 season. [1] As in 2018, two normal length races (Race 1 and Race 2) were held – one each on Saturday and Sunday (Friday and Saturday in Qatar).
The 2024 Superbike World Championship was the 37th season of the Superbike World Championship. Toprak Razgatlıoğlu, who had previously won the championship in 2021, won his second Superbike world title, [1] and marked BMW's first rider's title since entering world-level superbikes in 2011.
Rifapentine in pregnant women has not been studied, but animal reproduction studies have resulted in fetal harm and were teratogenic. If rifapentine or rifampin are used in late pregnancy, coagulation should be monitored due to a possible increased risk of maternal postpartum hemorrhage and infant bleeding. [2]
Isoniazid/rifampicin, also known as isoniazid/rifampin, is a medication used to treat tuberculosis. [1] It is a fixed dose combination of isoniazid and rifampicin (rifampin). [1] It is used together with other antituberculosis medication. [1] It is taken by mouth. [1] It is on the World Health Organization's List of Essential Medicines. [2]
Scientists at the Italian drug company Achifar discovered rifabutin in 1975. (Eventually Archifar became part of Farmitalia Carlo Erba, a unit of the conglomerate Montedison which was subsequently bought by Pharmacia) This company's Adria Laboratories subsidiary filed for Food and Drug Administration (FDA) approval of rifabutin under the brand name Mycobutin in the early 1990s and the drug ...